Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception

Fertility and Sterility

Volumn 78, Issue 6, 2002, Pages 1154-1158

  Mathur, Raj ^a,b   Hayman, Grant ^c   Bansal, Amolak ^c   Jenkins, Julian ^b  

^a Rosie Maternity Hospital   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Complications; IVF; OHSS; Prediction; VEGF

Indexed keywords

FOLLITROPIN; HYPOPHYSIS HORMONE; PROGESTERONE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HIGH RISK POPULATION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LUTEAL CELL; OUTCOMES RESEARCH; OVARY DISEASE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK; STATISTICAL ANALYSIS;

ADULT; EMBRYO TRANSFER; ENDOTHELIAL GROWTH FACTORS; FEMALE; FERTILIZATION IN VITRO; HUMANS; INCIDENCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUTEAL PHASE; LYMPHOKINES; OSMOLAR CONCENTRATION; OVARIAN HYPERSTIMULATION SYNDROME; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036905008     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)04243-7     Document Type: Article

References (20)

1. Semba S., Moriya T., Youssef E.M., Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int. 50:2000;549-552.
2. Mathur R.S., Akande A.V., Keay S.D., Hunt L.P., Jenkins J.M. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril. 73:2000;901-912.
3. Elchalal U., Schenker J.G. The pathophysiology of ovarian hyperstimulation syndrome - views and ideas. Hum Reprod. 12:1997;1129-1137.
4. Goldsman M.P., Pedram A., Dominguez C.E., Ciuffardi I., Levin E., Asch R.H. Increased capillary permeability induced by human follicular fluid a hypothesis for an ovarian origin of the hyperstimulation syndrome . Fertil Steril. 63:1995;268-272.
5. Amato P, Zwain I, Yen SSC. Identification of vascular endothelial growth factor in human follicular fluid: A possible role in ovarian hyperstimulation syndrome. Proceedings of the 52nd Annual Meeting of the American Society of Reproductive Medicine; Birmingham, Alabama. Boston:1996.
6. McClure N., Healy D.L., Rogers P.A., Sullivan J., Beaton L., Haning R.V. Jr, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet. 344:1994;235-236.
7. Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H.A., et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells importance in ovarian hyperstimulation syndrome . J Clin Endocrinol Metab. 80:1995;1967-1971.
8. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-32.
9. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol. 138:1991;213-221.
10. Abramov Y., Barak V., Nisman B., Schenker J.G. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril. 67:1997;261-265.
11. Agrawal R., Tan S.L., Wild S., Sladkevicius P., Engmann L., Payne N., et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril. 71:1999;287-293.
12. Agrawal R., Sladkevicius P., Engmann L., Conway G.S., Payne N.N., Bekis J., et al. Serum vascular endothelial growth factor and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod. 13:1998;651-655.
13. Friedman C.L., Seifer D.B., Kennard E.A., Arbogast L., Alak B., Danforth D.R. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril. 70:2000;836-839.
14. Chen C.D., Chen H.F., Lu H.F., Ho H.N., Yang Y.S. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Hum Reprod. 15:2000;1037-1042.
15. Polson D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries a common finding in normal women . Lancet. 1:1988;870-872.
16. Golan A., Ron-El R., Herman A., Soffer Y., Weinraub Z., Caspi E. Ovarian hyperstimulation syndrome an update review . Obstet Gynecol Surv. 44:1989;430-441.
17. Artini P.G., Fasciani A., Monti M., Luisi S., D'Ambrogio G., Gennaziani A.R., et al. Changes in serum vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization programme. Fertil Steril. 70:1998;560-564.
18. Ludwig M., Jelkman W., Bauer O., Diedrich K. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod. 14:1999;2437-2441.
19. Krasnow J.S., Berga S.L., Guzick D.S., Zeleznik A.J., Yeo K.T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome a preliminary report . Fertil Steril. 65:1996;552-555.
20. Wolfgang J. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem. 47:2001;617-623.